Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Latency: the hidden HIV-1 challenge.

Alessandro Marcello1

  • 1Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Padriciano, 99 - 34012 Trieste, Italy. marcello@icgeb.org

Retrovirology
|January 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In silico characterisation of a novel SARS-CoV-2 envelope protein inhibitor and in vitro validation against murine coronavirus.

Bioorganic chemistry·2026
Same author

SARS-CoV-2-induced damage to rat cortical neuronal networks ex vivo is mediated by the pro-inflammatory activation of the cGAS-STING pathway.

Journal of neurovirology·2025
Same author

Cellular Biology: Virus-Host Interactions and RNA Structure and Function.

Current topics in microbiology and immunology·2025
Same author

Colorimetric RT-LAMP for SARS-CoV-2 detection from nasopharyngeal swabs or crude saliva: a multicountry diagnostic accuracy study in Africa.

The Lancet. Global health·2025
Same author

Inhibition of ALKBH5 demethylase of m<sup>6</sup>A pathway potentiates HIV-1 reactivation from latency.

Virology journal·2025
Same author

SARS-CoV-2 Genetic Variants Identified in Selected Regions of Ethiopia Through Whole Genome Sequencing: Insights from the Fifth Wave of COVID-19.

Genes·2025

Current treatments cannot eradicate HIV-1. This review explores epigenetic mechanisms controlling viral latency in CD4 T cells, crucial for developing future eradication therapies.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Current antiretroviral therapy (ART) for Human Immunodeficiency Virus type 1 (HIV-1) does not achieve viral eradication.
  • Latent HIV-1 reservoirs, primarily in resting memory CD4 T cells, persist despite ART and can cause viral rebound upon treatment cessation.
  • The molecular mechanisms governing long-term transcriptional silencing of HIV-1 provirus in these reservoirs are not fully understood.

Purpose of the Study:

  • To review the current understanding of HIV-1 latency establishment and maintenance.
  • To focus on the role of epigenetic mechanisms, particularly chromatin modifications, in controlling proviral transcription in CD4 T cells.
  • To provide insights for developing novel therapeutic strategies aimed at HIV-1 eradication.

Main Methods:

Related Experiment Videos

  • This is a review article, synthesizing existing research.
  • Focuses on analyzing molecular mechanisms of transcriptional control.
  • Examines epigenetic regulation, including chromatin remodeling and histone modifications.

Main Results:

  • HIV-1 latency is maintained by complex epigenetic mechanisms that silence proviral gene expression.
  • Resting memory CD4 T cells are a key cellular reservoir for persistent, transcriptionally silent HIV-1.
  • Understanding these epigenetic controls is essential for targeting latent reservoirs.

Conclusions:

  • Effective HIV-1 eradication requires targeting latent viral reservoirs.
  • Epigenetic regulation of chromatin plays a critical role in maintaining HIV-1 latency.
  • Further research into these molecular mechanisms is necessary for developing curative therapies.